NAMMI THERAPEUTICS

LIVE

Serial Number

88317134

Owner

NAMMI THERAPEUTICS, INC.,

Attorney

Britt L. Anderson

First Use Date

Sep 16, 2019

Filing Date

Feb 26, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

NAMMI THERAPEUTICS Trademark

Serial Number: 88317134 • Registration: 5916753

NAMMI THERAPEUTICS is a trademark filed by NAMMI THERAPEUTICS, INC., on February 26, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

NAMMI THERAPEUTICS, INC., (5 trademarks)

10940 Wilshire Blvd,
LOS ANGELES, CA 90024

Entity Type: 03

NAMMI OPS, INC. (2 trademarks)

11111 SANTA MONICA BLVD., STE 1700
LOS ANGELES, CA 90025

Entity Type: 03

Legal Representation

Attorney of Record

Britt L. Anderson

1,640 trademarks filed View all →

Correspondence Address

Britt L. Anderson Perkins Coie LLP

3150 PORTER DR.

PALO ALTO, CA 94304

United States

Trademark Details

Filing Date

February 26, 2019

Registration Date

November 19, 2019

First Use Anywhere

September 16, 2019

First Use in Commerce

September 16, 2019

Published for Opposition

June 25, 2019

Goods & Services

Pharmaceutical preparations for use in immunotherapy; tumor suppressing agents; pharmaceutical products for the treatment of cancer and tumors; pharmaceuticals, namely, immunogenic cell death inducers; therapeutic agents for promotion of cancer immunity

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Apr 5, 2025 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Apr 5, 2025 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Apr 5, 2025 APRE

TEAS SECTION 8 & 15 RECEIVED

Dec 20, 2024 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Nov 19, 2024 REM1

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Mar 31, 2021 ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Mar 3, 2021 ASGN

REGISTERED-PRINCIPAL REGISTER

Nov 19, 2019 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 12, 2019 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 11, 2019 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Oct 7, 2019 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 7, 2019 AITU

USE AMENDMENT FILED

Sep 17, 2019 IUAF

TEAS STATEMENT OF USE RECEIVED

Sep 17, 2019 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 20, 2019 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 25, 2019 NPUB

PUBLISHED FOR OPPOSITION

Jun 25, 2019 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 5, 2019 NONP

ASSIGNED TO LIE

May 20, 2019 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

May 7, 2019 CNSA

EXAMINER'S AMENDMENT ENTERED

May 7, 2019 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 7, 2019 GNEN

EXAMINERS AMENDMENT E-MAILED

May 7, 2019 GNEA

EXAMINERS AMENDMENT -WRITTEN

May 7, 2019 CNEA

ASSIGNED TO EXAMINER

May 7, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 18, 2019 NWOS

NEW APPLICATION ENTERED

Mar 1, 2019 NWAP

Related Trademarks

More from this Owner

NAMMI THERAPEUTICS

More in Same Class

GREEK GOD SUPPLEMENTS

SQWINCHER